Sundowning and circadian rhythm disorders in dementia.

Sleep disorders and disruptive nocturnal behaviours are commonly reported in people with senile dementia and present both a significant clinical problem and a cause of increased stress for caregivers. Neuronal degeneration of cholinergic Nucleus basalis Meynert (NBM) neurons promote rest-activity disturbance and Sundowning in Alzheimer's disease. NBM neurons modulate the activity of the mainly cholinergic suprachiasmatic nucleus (SCN) and the induction of NONREM sleep. Sundowning might be explained as a syndrome occurring when arousal is to be processed while the neocortex is already turned "off" to (NONREM) sleep. The therapeutic measures should thus primarily be aimed at the stimulation of the circadian system and enforcing "external Zeitgebers". Pharmacologically, application of cholinergic enhancers i.e. cholinesterase inhibitors and melatonin supports and should stabilize the weakened structures.

[1]  D. Swaab,et al.  The human pineal gland and melatonin in aging and Alzheimer's disease , 2005, Journal of pineal research.

[2]  E. Sforza,et al.  The PAM-RL ambulatory device for detection of periodic leg movements: a validation study. , 2005, Sleep medicine.

[3]  K. Jellinger.  Alterations of muscarinic acetylcholine receptor subypes in diffuse Lewy body disease: relation to Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[4]  A. Burns,et al.  Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease , 2004, International journal of geriatric psychiatry.

[5]  S. Finkel,et al.  Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics , 2005, International Psychogeriatrics.

[6]  G. Hajak,et al.  Noctural myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[7]  R. Ravid,et al.  Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. , 2003, The Journal of clinical endocrinology and metabolism.

[8]  J. Yesavage,et al.  The Relations among Caregiver Stress, “Sundowning” Symptoms, and Cognitive Decline in Alzheimer's Disease , 1992, Journal of the American Geriatrics Society.

[9]  R. Bullock.  Cholinesterase Inhibitors and Vascular Dementia , 2004, CNS drugs.

[10]  M. Okawa,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Diminished Melatonin Secretion in the Elderly Caused by Insufficient Environmental Illumination* , 2022 .

[11]  L. Evans.  Sundown Syndrome in Institutionalized Elderly , 1987, Journal of the American Geriatrics Society.

[12]  J. Sirviö,et al.  Relationship between the cortical choline acetyltransferase content and EEG delta-power , 1990, Neuroscience Research.

[13]  A. Bava,et al.  Rivastigmine in subcortical vascular dementia: A randomized, controlled, open 12-month study in 208 patients , 2003, American journal of Alzheimer's disease and other dementias.

[14]  D J Foley,et al.  Sleep complaints among elderly persons: an epidemiologic study of three communities. , 1995, Sleep.

[15]  L. Thal,et al.  A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. , 2003, Sleep.

[16]  Jelle Jolles,et al.  Subjective sleep problems in later life as predictors of cognitive decline. Report from the Maastricht Ageing Study (MAAS) , 2002, International journal of geriatric psychiatry.

[17]  S. Kasper,et al.  The effects of light therapy on mini-mental state examination scores in demented patients , 2001, Biological Psychiatry.

[18]  A. Prochazka,et al.  Leg symptoms in outpatient veterans. , 1991, The Western journal of medicine.

[19]  S. Ancoli-Israel,et al.  Illumination levels in nursing home patients: effects on sleep and activity rhythms , 2000, Journal of sleep research.

[20]  P. Mcgeer,et al.  Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain , 1984, Neurology.

[21]  D. Aarsland,et al.  Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study , 2002, Journal of neurology, neurosurgery, and psychiatry.

[22]  L. Burgio,et al.  Temporal patterns of disruptive vocalization in elderly nursing home residents , 2001, International journal of geriatric psychiatry.

[23]  S. Endo,et al.  Effects of bright light on cognitive and sleep–wake (circadian) rhythm disturbances in Alzheimer‐type dementia , 2000, Psychiatry and clinical neurosciences.

[24]  E. Rüther,et al.  Pergolide: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). Longterm follow up on pergolide , 1998, Journal of Neural Transmission.

[25]  V. Gribkoff,et al.  Molecular Dissection of Two Distinct Actions of Melatonin on the Suprachiasmatic Circadian Clock , 1997, Neuron.

[26]  A. Nuñez,et al.  Unit activity of rat basal forebrain neurons: Relationship to cortical activity , 1996, Neuroscience.

[27]  D. Kripke,et al.  Age‐Related Changes of Circadian Rhythms and Sleep‐Wake Cycles , 2003, Journal of the American Geriatrics Society.

[28]  T. Pollmächer,et al.  Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. , 1999, Journal of clinical psychopharmacology.

[29]  E. Koyama,et al.  Sleep improvement by light in a demented aged individual , 1998, Psychiatry and clinical neurosciences.

[30]  Rochelle E Tractenberg,et al.  The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease , 2003, Journal of sleep research.

[31]  G. Stoppe,et al.  Behavioural Problems Associated With Dementia , 1999, Drugs & aging.

[32]  T. Wetter,et al.  Restless Legs Syndrome Probably Induced by Risperidone Treatment , 2002, Pharmacopsychiatry.

[33]  R. Doody,et al.  Donepezil in vascular dementia , 2003, Neurology.

[34]  C. Pollak,et al.  The role of actigraphy in the study of sleep and circadian rhythms. , 2003, Sleep.

[35]  G. E. Pickard,et al.  Subcellular distribution of 5‐HT1b and 5‐HT7 receptors in the mouse suprachiasmatic nucleus , 2001, The Journal of comparative neurology.

[36]  H. Soininen,et al.  Cholinergic deficit in Alzheimer's disease: A study based on CSF and autopsy data , 1988, Neurochemical Research.

[37]  B. Rovner,et al.  Sedative-hypnotic use by the elderly: Effects on hospital length of stay and costs , 1997, The journal of mental health administration.

[38]  M. Steriade.  Acetylcholine systems and rhythmic activities during the waking--sleep cycle. , 2004, Progress in brain research.

[39]  V. Mor,et al.  Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics. , 2005, The Journal of clinical psychiatry.

[40]  C. Pollak,et al.  Sleep problems in the community elderly as predictors of death and nursing home placement , 1990, Journal of Community Health.

[41]  G. Small,et al.  Long‐term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease , 2003, European journal of neurology.

[42]  M Barinaga.  How Jet-Lag Hormone Does Double Duty in the Brain , 1997, Science.

[43]  E. Perry,et al.  Lewy body dementia--clinical, pathological and neurochemical interconnections. , 1997, Journal of neural transmission. Supplementum.

[44]  M. Mirmiran,et al.  Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients , 1997, Biological Psychiatry.

[45]  D. Bliwise.  What is sundowning? , 1994, Journal of the American Geriatrics Society.

[46]  S. Ancoli-Israel,et al.  CIRCADIAN RHYTHMS OF AGITATION IN INSTITUTIONALIZED PATIENTS WITH ALZHEIMER'S DISEASE , 2000, Chronobiology international.

[47]  S. Endo,et al.  Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. , 2003, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[48]  C. Lyketsos,et al.  A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long‐term care , 1999, International journal of geriatric psychiatry.

[49]  Douglas Galasko,et al.  Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study , 2000, International journal of geriatric psychiatry.

[50]  B. C. Manning,et al.  Sundowning and circadian rhythms in Alzheimer's disease. , 2001, The American journal of psychiatry.

[51]  H. Yamashita,et al.  Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome. , 1999, International clinical psychopharmacology.

[52]  I. Smith,et al.  The validation of a new actigraphy system for the measurement of periodic leg movements in sleep. , 2005, Sleep medicine.

[53]  A. Nicolas,et al.  Restless legs syndrome improved by pramipexole , 1999, Neurology.

[54]  R. Chervin,et al.  Sleep apnea in patients with transient ischemic attack and stroke , 1996, Neurology.

[55]  R. Cacabelos,et al.  APOE-related frequency of cognitive and noncognitive symptoms in dementia. , 1996, Methods and findings in experimental and clinical pharmacology.

[56]  E. Gräßel.  Warum pflegen Angehörige? Ein Pflegemodell für die häusliche Pflege im höheren Lebensalter , 2000 .

[57]  D F Kripke,et al.  Periodic limb movements in sleep in community-dwelling elderly. , 1991, Sleep.

[58]  P. Lavie.  Melatonin: Role in Gating Nocturnal Rise in Sleep Propensity , 1997, Journal of biological rhythms.

[59]  D. Cardinali,et al.  The use of melatonin in Alzheimer's disease. , 2002, Neuro endocrinology letters.

[60]  S. Ancoli-Israel,et al.  Effect of light on agitation in institutionalized patients with severe Alzheimer disease. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[61]  A. Satlin,et al.  Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. , 1992, The American journal of psychiatry.

[62]  J. D. Miller.  On the nature of the circadian clock in mammals. , 1993, The American journal of physiology.

[63]  Ian G. McKeith,et al.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.

[64]  H. Feldman,et al.  A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease , 2001, Neurology.

[65]  Anna Wirz-Justice,et al.  Dawn–dusk simulation light therapy of disturbed circadian rest–activity cycles in demented elderly , 2003, Experimental Gerontology.

[66]  D. Dijk,et al.  Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. , 2006, Sleep.

[67]  S. Ancoli-Israel,et al.  Adherence to continuous positive airway pressure treatment in patients with Alzheimer's disease and obstructive sleep apnea. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[68]  Jennifer L Martin,et al.  Nighttime oxygen desaturation and symptoms of sleep-disordered breathing in long-stay nursing home residents. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[69]  Serge Gauthier,et al.  Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial , 2002, The Lancet.

[70]  D. Coakley,et al.  BEHAVIOUR DISTURBANCE AND OTHER PREDICTORS OF CARER BURDEN IN ALZHEIMER'S DISEASE , 1997, International journal of geriatric psychiatry.

[71]  Yaniv Assaf,et al.  Sleep-anticipating effects of melatonin in the human brain , 2006, NeuroImage.

[72]  J. Birks,et al.  Donepezil for vascular cognitive impairment. , 2004, The Cochrane database of systematic reviews.

[73]  D. White,et al.  Antidepressants and Periodic Leg Movements of Sleep , 2005, Biological Psychiatry.

[74]  V. Gribkoff,et al.  Targeted Disruption of the Mouse Mel1b Melatonin Receptor , 2003, Molecular and Cellular Biology.

[75]  C Eisdorfer,et al.  Music therapy increases serum melatonin levels in patients with Alzheimer's disease. , 1999, Alternative therapies in health and medicine.

[76]  N. Kutner,et al.  Observed sleep/wakefulness and severity of dementia in an Alzheimer's disease special care unit. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[77]  E. Perry,et al.  Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial , 2000, International journal of geriatric psychiatry.

[78]  Kristine Yaffe,et al.  Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. , 2003, JAMA.

[79]  J. Warner,et al.  Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia , 2002, International journal of geriatric psychiatry.

[80]  R. Sival,et al.  Bright light therapy and melatonin in motor restless behaviour in dementia: a placebo‐controlled study , 2001, International journal of geriatric psychiatry.

[81]  S. Salloway,et al.  Efficacy and Tolerability of Donepezil in Vascular Dementia: Positive Results of a 24-Week, Multicenter, International, Randomized, Placebo-Controlled Clinical Trial , 2003, Stroke.

[82]  D. Bliwise,et al.  Polysomnographic correlates of spontaneous nocturnal wetness episodes in incontinent geriatric patients. , 2004, Sleep.